SB

Sheela Babu Johny

Active Director Director DIN 08170160
DIN 08170160 First appointment Jun 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2018
Shareholding value •••• Premium profile

About Sheela Babu Johny

Data last updated:

Sheela Babu Johny is a Director at J And J Kalan Pharmacy Private Limited (since 2018). The company operates in Pharma. J And J Kalan Pharmacy Private Limited reported revenue of ₹65.7 Lakh (FY 2025).

DIN 08170160
Primary Designation Director
Industry Pharma
First Appointment 27 Jun 2018
Oldest Company Age 23 yrs
Largest company J And J Kalan Pharmacy Private Limited · ₹65.7 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Jun 20182003₹65.7 Lakh (FY 2025)Active

Board colleagues of Sheela Babu Johny

Directorship timeline

Open interactive timeline →
J And J Kalan Pharmacy Private Limited
Premium access

Shareholding and investment profile for Sheela Babu Johny

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sheela Babu Johny

Sheela Babu Johny currently holds 1 directorship: J And J Kalan Pharmacy Private Limited (Director, since 27 Jun 2018, revenue ₹65.7 Lakh (FY 2025)).

Sheela Babu Johny was first appointed on 27 Jun 2018 as Director at J And J Kalan Pharmacy Private Limited.

The current boards of Sheela Babu Johny's companies include Jose Kochuvareed Kalan (J And J Kalan Pharmacy Private Limited), Lissy Jose (J And J Kalan Pharmacy Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available